(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

TBIO

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

TBIO

ST13

US500000086456235

Classe

5, 42

Pedido

86456235

Registro

6202962

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

73

Atualização mais recente

25/11/2025

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

5, 42

Data de depósito

17/11/2014

Data de registro

24/11/2020

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

24/11/2020

Última transação

25/11/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use, Foreign priority

Código do desenho

4

Tipo de titular

03

Localização do titular

Toronto, Ontario, CA

Examinador

MEYERS,MORGAN LAURA

Unidade examinadora

M80

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

Turnstone Biologics Inc.

Representantes

Tye Biasco Patterson Thuente Pedersen, P.A.

Classificação técnica

Classes Nice

Classe 5Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Oncolytic viruses namelyoncolytic vaccinesviral vectors for gene delivery or protein expression from the gene; pharmaceutical compounds and products for the prevention and treatment of cancer and infectious diseasesbiochemicals in the form of monoclonal antibodies for the treatment of cancer and chronic viral infectionsbiochemicals in the form of monoclonal antibodies for research useprotein and peptides for the treatment of cancer and chronic viral infectionspharmaceuticals and vaccines for human and veterinary use for the treatment of cancer and chronic viral infections

Classe 42

Research and development in connection with oncolytic viruses and oncolytic vaccinesviral vectorspharmaceutical compounds and products in the field of cancer and infectious diseasesantibodies in the field of cancer and infectious diseasesprotein and peptide products in the field of cancer and infectious diseases and pharmaceutical and vaccine products in the field of cancer and infectious disease

Publicações

Histórico de despachos e eventos da marca no USPTO.

73 publicações encontradas

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

24/11/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

24/11/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/09/2020

PUBO

PUBLISHED FOR OPPOSITION

08/09/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

19/08/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

31/07/2020

XAEC

EXAMINER'S AMENDMENT ENTERED

31/07/2020

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

31/07/2020

GNEA

EXAMINERS AMENDMENT E-MAILED

31/07/2020

CNEA

EXAMINERS AMENDMENT -WRITTEN

31/07/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

22/07/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

21/07/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

21/07/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

21/01/2020

GNRT

NON-FINAL ACTION E-MAILED

21/01/2020

CNRT

NON-FINAL ACTION WRITTEN

21/01/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

30/12/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

30/12/2019

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

19/12/2019

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

12/09/2019

GNSI

INQUIRY TO SUSPENSION E-MAILED

12/09/2019

CNSI

SUSPENSION INQUIRY WRITTEN

12/09/2019

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

28/08/2019

ALIE

ASSIGNED TO LIE

15/08/2019

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/08/2019

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/08/2019

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

14/02/2019

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

02/08/2018

ALIE

ASSIGNED TO LIE

02/08/2018

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

22/01/2018

GNSL

LETTER OF SUSPENSION E-MAILED

22/01/2018

CNSL

SUSPENSION LETTER WRITTEN

22/01/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

19/01/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

19/01/2018

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

17/01/2018

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

22/12/2017

GNSI

INQUIRY TO SUSPENSION E-MAILED

22/12/2017

CNSI

SUSPENSION INQUIRY WRITTEN

22/12/2017

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

12/12/2017

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

08/06/2017

GNSL

LETTER OF SUSPENSION E-MAILED

08/06/2017

CNSL

SUSPENSION LETTER WRITTEN

08/06/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/06/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/06/2017

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

05/06/2017

RCSC

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED

05/01/2017

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

15/12/2016

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

11/06/2016

GNSL

LETTER OF SUSPENSION E-MAILED

11/06/2016

CNSL

SUSPENSION LETTER WRITTEN

11/06/2016

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

26/05/2016

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

26/05/2016

ALIE

ASSIGNED TO LIE

19/05/2016

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

09/05/2016

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

23/11/2015

GNSI

INQUIRY TO SUSPENSION E-MAILED

23/11/2015

CNSI

SUSPENSION INQUIRY WRITTEN

23/11/2015

RCCK

SUSPENSION CHECKED - TO ATTORNEY FOR ACTION

02/11/2015

ALIE

ASSIGNED TO LIE

02/11/2015

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

01/05/2015

GNSL

LETTER OF SUSPENSION E-MAILED

01/05/2015

CNSL

SUSPENSION LETTER WRITTEN

01/05/2015

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

30/04/2015

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

30/04/2015

ALIE

ASSIGNED TO LIE

30/04/2015

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

28/04/2015

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

14/03/2015

GNRT

NON-FINAL ACTION E-MAILED

14/03/2015

CNRT

NON-FINAL ACTION WRITTEN

14/03/2015

DOCK

ASSIGNED TO EXAMINER

07/03/2015

MPMK

NOTICE OF PSEUDO MARK E-MAILED

25/11/2014

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

24/11/2014

NWAP

NEW APPLICATION ENTERED

20/11/2014

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace TBIO ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.